University of Louisville Journal of Respiratory Infections

CASE REPORT

Pulmonary Embolism Related to COVID-19 Quarantine
Eduardo J. Quinteros1∗ , MD; Juan Bissonni2 , MD
1

Internal Medicine and Cardiology, Clı́nica Privada Mayo, Bell Ville, Argentina; 2 Images Diagnosis/Radiology, Diagnóstico por Imágenes Sudeste, Bell Ville, Argentina
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Abstract
The mandatory quarantine imposed in response to the
COVID-19 pandemic has been related to an increase in cases
of thromboembolism in non-COVID-19 patients. Particularly
in countries like Argentina where strict quarantine was mandated, individuals were far less likely to risk being outside or

observing healthy practices that would maintain the exacerbation of diseases such as thromboembolism. We report the
case of a patient with pulmonary thromboembolism without
usual triggering causes during the quarantine period, related
to a previously undiagnosed hypercoagulable condition.

Introduction

Two hours earlier, he had participated in mild physical activities without experiencing any symptoms. His
medical records were significant: Type II diabetes,
high blood pressure, mild carotid vascular disease, and
obesity. The patient was current with all scheduled
metabolic and blood pressure checkups as well as regularly administered doses of aspirin, except for the last
seven days, which he had forgotten .Ten years before,
he had suffered from deep vein thrombosis during a
long flight. On that occasion, he had not been diagnosed with any predictor. The patient did not have any
problems with being in lockdown, but his physical activity had fallen significantly since the beginning of the
lockdown.

Quarantine imposed by different countries due to the
COVID-19 pandemic has resulted in increased cases of
thromboembolism in non-COVID-19 patients.[1, 2] In
Argentina, to prevent the spread of the coronavirus,
the president announced mandatory quarantine and
citizens with jobs described as non-essential had to
be confined to their usual residences or to the place
where they were at when he announced nationwide
lockdown. Citizens had to refrain from attending their
workplaces except for essential workers and emergency care providers. Moreover, any public or private
event or activity as well as schooling and social gatherings were cancelled. People were not allowed to travel
on the roads and freeways unless they had to carry
out the essential jobs described on the official list, like
the case of transportation of essential cleaning supplies,
medicine, and food.[3]

Case Presentation
Thirty-seven days after the mandatory quarantine imposed in Argentina after March 2020, which forced
everyone except for essential workers and employees of other emergency care situations into lockdown,
a 64-year-old man living in Departamento Unión of
Córdoba Province (without community viral circulation) consulted his primary care physician for acute
dyspnea to minor habitual efforts.[3] The patient realized the symptoms after a short postprandial walk.
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The patient was sent to a cardiology clinic, where he
was admitted 48 hours after the initial symptoms because of continuing symptoms. The delay in admittance was due in large part because of his fear of
contracting SARS-CoV-2. He did not have fever or
any other respiratory symptoms, or trips to areas with
SARS-CoV-2, viral outbreak, or close contact with a patient with a COVID-19 diagnosis. He had no angina,
palpitations, syncope, or dyspnea at rest. The patient
did not have any other symptoms at rest, and his axillary temperature was 36.4 °C and his radial pulse rate
was 100 bpm. The patient had slight arterial oxygen
desaturation by oximetry (89% with ambient air) and
an S3 on auscultation, without physical signs of venous
thrombosis. The findings of his examination and laboratory tests are summarized in Table 1.
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Table 1. Patient examinations and laboratory findings.

Blood pressure
Heart Rate
Respiratory Rate
Saturation O2 Oximetry
Temperature
ECG
D dimer
Protrombine Time
PCR
Glucemia

100/70 mmhg
110 lpm, regular, rhythmic
18 rpm at rest
89% with ambient air
36.4°C
Sinusal tachycardia
198 ng/ml (VN<200 ng/ml)
21.1 seg RIN 1,66
<6 mg/l
128 mg%

Figure 1. Lung angio-tomography.

The diagnostic impression was hypoxemic respiratory failure secondary to acute pulmonary thromboembolism (PE). The risk chances of PE were calculated
with the GENEVA Score at 8 points (moderate risk), the
Wells Score at 9 points (high risk of PE), and the PESI
Score at 114 points (high risk).
A POCUS pulmonary ultrasound and a POCUS
echocardiogram showed an “A” profile at the pulmonary level (BLUE Protocol).[4] It also showed evidence of a left ventricular hypertrophy, with hyperdynamic systolic function of the left ventricle and dilation
and systolic dysfunction of the right ventricle. At this,
the patient received anticoagulation.

material which partially blocked the vascular lumen,
compatible with acute PE, was found in the lobar and
segmental branches of all lobes (Figure 1).
A SARS-CoV-2 PCR was not performed because the patient did not present with the local case definition criteria at the time of admission. Anticoagulation with
sodium heparin, oxygen at 3L/minute, and boluses of
saline crystalloids were administered with good outcome. The subsequent workup for other patient-related
factors predisposing him for venous thromboembolism
revealed Antiphospholipid Syndrome with evidence
of a circulating anticoagulant (lupus anticoagulant)
(Table 2). It was decided that the patient was going
to remain anticoagulated in the long term.[5]

A formal subsequent venous ultrasound did not find
evidence of deep vein thrombosis. However, a chest
angio-tomography revealed a pulmonary artery caliber
of 30mm in the trunk that was found to be patent as
well as the right and left main branches. Hypodense
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Table 2. Subsequent workup for other patient-related factors.

Circulating anticoagulant
Protein C
Ac Against phospholipids IgC
Ac Agains phospholipids IgM 1
Ac Anticardiolipin igG,IgM
Ac Antinuclear
Reumatoid Factor
Protein S

Discussion
This case study of acute PE contributes to the field by
offering new evidence of the increased risk of highrisk thromboembolic situations. In this case, the situation presented in a patient with unusual triggering factors under the conditions of decreased physical activity
due to the SARS-CoV-2 pandemic quarantine with the
presence of Antiphospholipid Syndrome.[1-3] A delay
in consulting a physician due to fear of becoming in-
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LA1 126
LA2 50, normalized reason 2.54
112%
1.7 (normal)
Normal
Negative
Negative
Negative
88% normal

fected while visiting health care areas increased this
risk. Cases such as the one described above show the
need to evaluate the risk/benefit to health outcomes
from strict/mandatory quarantines in areas without viral circulation, and the need to give sound advice to
patients with known risks. In the case study described,
the risk of developing thromboembolism in quarantine
can be equated with the risk a person can have during
a long flight.
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